- Jul 2018
-
europepmc.org europepmc.org
-
On 2015 Sep 16, Geriatric Medicine Journal Club commented:
The related study (Delayed-start analysis: Mild Alzheimer's disease patients in solanezumab trials, 3.5 years. Alzheimer's & Dementia: Translational Research & Clinical Interventions. In press. 2015) was critically appraised at the August 2015 Geriatric Medicine Journal Club (follow #GeriMedJC on Twitter). The full discussion can be found at: http://gerimedjc.blogspot.com/2015/09/study-author-joins-us-for-successful.html?spref=tw This is an interesting study design, but the hype around the results may be disproportionate or premature to the magnitude of clinically meaningful benefit shown.
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.
-
- Feb 2018
-
europepmc.org europepmc.org
-
On 2015 Sep 16, Geriatric Medicine Journal Club commented:
The related study (Delayed-start analysis: Mild Alzheimer's disease patients in solanezumab trials, 3.5 years. Alzheimer's & Dementia: Translational Research & Clinical Interventions. In press. 2015) was critically appraised at the August 2015 Geriatric Medicine Journal Club (follow #GeriMedJC on Twitter). The full discussion can be found at: http://gerimedjc.blogspot.com/2015/09/study-author-joins-us-for-successful.html?spref=tw This is an interesting study design, but the hype around the results may be disproportionate or premature to the magnitude of clinically meaningful benefit shown.
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.
-